-
19834-500An HDAC inhibitor (IC<sub>50</sub>s = 29 nM, 62 nM, and 1.09 µM for HDAC1, 2, and 3, respectively) possesses preferential binding kinetics with seven-fold longer half-life on HDAC2 compared to HDAC1 (143 min vs. 20 min).
-
19836-1An HDAC inhibitor (IC<sub>50</sub>s = 21 nM, 100 nM, and 11.48 µM for HDAC1, 2, and 3, respectively) possesses six6-fold extended half-life for binding on HDAC2 compared to HDAC1 (381 min vs.
-
19836-10An HDAC inhibitor (IC<sub>50</sub>s = 21 nM, 100 nM, and 11.48 µM for HDAC1, 2, and 3, respectively) possesses six6-fold extended half-life for binding on HDAC2 compared to HDAC1 (381 min vs.
-
19836-5An HDAC inhibitor (IC<sub>50</sub>s = 21 nM, 100 nM, and 11.48 µM for HDAC1, 2, and 3, respectively) possesses six6-fold extended half-life for binding on HDAC2 compared to HDAC1 (381 min vs.
-
16919-10A small molecule inhibitor that potently and selectively inhibits both HDAC6 and HDAC8 (IC<sub>50</sub>s = 36 and 120 nM, respectively).
-
16919-5A small molecule inhibitor that potently and selectively inhibits both HDAC6 and HDAC8 (IC<sub>50</sub>s = 36 and 120 nM, respectively).
-
19143-1BRD7552 is a small molecule that induces expression of pancreatic and duodenal homeobox 1 (PDX1), a transcription factor involved in pancreas development and function. BRD7552 dose-dependently increases PDX1 and insulin gene expression, as well as
-
19143-10BRD7552 is a small molecule that induces expression of pancreatic and duodenal homeobox 1 (PDX1), a transcription factor involved in pancreas development and function. BRD7552 dose-dependently increases PDX1 and insulin gene expression, as well as
-
19143-25BRD7552 is a small molecule that induces expression of pancreatic and duodenal homeobox 1 (PDX1), a transcription factor involved in pancreas development and function. BRD7552 dose-dependently increases PDX1 and insulin gene expression, as well as
-
19143-5BRD7552 is a small molecule that induces expression of pancreatic and duodenal homeobox 1 (PDX1), a transcription factor involved in pancreas development and function. BRD7552 dose-dependently increases PDX1 and insulin gene expression, as well as
-
11861-10A natural fungal metabolite which reversibly interferes with protein trafficking and secretion mediated by the Golgi apparatus and endoplasmic reticulum directly and reversibly inhibits Sec7 domain-containing GEFs which are necessary for Arf
-
11861-25A natural fungal metabolite which reversibly interferes with protein trafficking and secretion mediated by the Golgi apparatus and endoplasmic reticulum directly and reversibly inhibits Sec7 domain-containing GEFs which are necessary for Arf